Alignment Healthcare Inc (ALHC) concluded trading on Thursday at a closing price of $16.77, with 10.26 million shares of worth about $172.08 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 45.32% during that period and on May 01, 2025 the price saw a loss of about -5.36%. Currently the company’s common shares owned by public are about 191.78M shares, out of which, 109.98M shares are available for trading.
Stock saw a price change of -7.04% in past 5 days and over the past one month there was a price change of -7.25%. Year-to-date (YTD), ALHC shares are showing a performance of 49.07% which increased to 230.12% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.14 but also hit the highest price of $21.06 during that period. The average intraday trading volume for Alignment Healthcare Inc shares is 2.72 million. The stock is currently trading -8.58% below its 20-day simple moving average (SMA20), while that difference is down -0.99% for SMA50 and it goes to 30.56% higher than SMA200.
Alignment Healthcare Inc (NASDAQ: ALHC) currently have 191.78M outstanding shares and institutions hold larger chunk of about 55.13% of that.
The stock has a current market capitalization of $3.32B and its 3Y-monthly beta is at 1.33. It has posted earnings per share of -$0.67 in the same period. It has a debt-to-equity ratio of 3.39. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALHC, volatility over the week remained 4.61% while standing at 6.18% over the month.
Analysts are in expectations that Alignment Healthcare Inc (ALHC) stock would likely to be making an EPS of 0.01 in the current quarter, while forecast for next quarter EPS is 0.02 and it is 0.11 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.02 which is 0.03 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.03 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 44.16% while it is estimated to increase by 58.20% in next year. EPS is likely to grow at an annualized rate of 62.27% for next 5-years, compared to annual growth of -22.95% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Stephens on December 03, 2024 offering an Overweight rating for the stock and assigned a target price range of between $13 and $17 to it. On May 30, 2024, BofA Securities Upgrade their recommendations, while on May 30, 2024, Robert W. Baird Initiated their ratings for the stock with a price target of $10. Stock get an Overweight rating from Piper Sandler on May 08, 2024.
